Skip to content

Text Messages to improve HIV Antiretroviral Therapy Compliance

The use of Text Messages in adherence to Antiretroviral Treatment

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-9nt9hv
Enrollment
Unknown
Registered
2018-07-13
Start date
2016-07-11
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV

Interventions

Control group: 57 HIV-infected patients on antiretroviral therapy for at least 3 months, will receive text messages on the cell phone informing them of appointment reminders and monthly check-in of re
Device
Behavioural
Other

Sponsors

Universidade Federal de Santa Maria
Lead Sponsor
Hospital Universitário de Santa Maria
Collaborator

Eligibility

Age
15 Years to No maximum

Inclusion criteria

Inclusion criteria: The inclusion criteria for participation in the study will be: people infected with HIV and on antiretroviral treatment; Be on medication for at least 3 months; (15 years or older), according to UNAIDS criteria.

Exclusion criteria

Exclusion criteria: The exclusion criteria will be: to present some cognitive and mental limitation (which impairs comprehension and / or verbal expression); To be in prison, a Access to mobile phones; Not knowing how to read if the person does not use tools that allow the reading of the message, since the intervention will be carried out by means of a text message; Women in the gestational period, since there is evidence that during this period there is an increase in adherence.

Design outcomes

Primary

MeasureTime frame
Expected outcome 1: An increase in the antiretroviral treatment adherence score in the 180-day period, verified by means of the t-test of paired samples from the observation of a variation of at least 5% in pre- and post-intervention measurements. The outcome will be assessed by the degree of adherence to antiretroviral treatment by the "Questionnaire for assessing adherence to antiretroviral treatment in people with HIV / AIDS."

Secondary

MeasureTime frame
Expected outcome 2: An increase in the expectation of self-efficacy score in the 180-day period, verified by means of the t-test of paired samples from the observation of a variation of at least 5% in pre- and post-intervention measurements. The outcome will be evaluated by the Self Efficacy Scale for Adherence to Antiretroviral Treatment to follow antiretroviral prescription.;Expected outcome 3: An increase in the social support score in the 180-day period, verified by means of the t-test of paired samples from the observation of a variation of at least 5% in pre- and post-intervention measurements. The outcome will be assessed by the Social Support Scale for people living with HIV / AIDS.;Expected outcome 4: An increase in the quality of life score in the 180-day period, verified by means of the t-test of paired samples from the observation of a variation of at least 5% in pre- and post-intervention measurements. The outcome will be developed by the Instrument of Quality of Life directed to people with HIV / AIDS

Countries

Brazil

Contacts

Public ContactStela de Mello Padoin

Universidade Federal de Santa Maria

stelamaris_padoin@hotmail.com+55-55-999713143

Outcome results

None listed

Source: REBEC (via WHO ICTRP)